Jeong Il Yu

A randomized phase III trial comparing adjuvant single-agent S1, S-1 with oxaliplatin, and postoperative chemoradiation with S-1 and oxaliplatin in patients with node-positive gastric cancer after D2 resection: the ARTIST 2 trial☆

S.H. Park, D.H. Lim, Tae Sung Sohn et al. · Annals of Oncology · 2020 · 286 citations · Full text

Medicine, Oncology, Surgery +17

Multidisciplinary approach is associated with improved survival of hepatocellular carcinoma patients

Dong Hyun Sinn, Gyu-Seong Choi, Hee Chul Park et al. · PLoS ONE · 2019 · 94 citations · Full text

Medicine, Oncology, Surgery +17

Radiotherapeutic strategies for hepatocellular carcinoma with portal vein tumour thrombosis in a hepatitis B endemic area

Jung Ho Im, Sang Min Yoon, Hee Chul Park et al. · Liver International · 2016 · 77 citations · Full text

Medicine, Oncology, Radiation Oncology +12

The feasibility of combined transcatheter arterial chemoembolization and radiotherapy for advanced hepatocellular carcinoma

Ju‐Yeon Cho, Yong‐Han Paik, Hee Chul Park et al. · Liver International · 2013 · 66 citations

Medicine, Oncology, Surgery +15

Differences in prognostic factors and patterns of failure between invasive micropapillary carcinoma and invasive ductal carcinoma of the breast: Matched case–control study

Jeong Il Yu, Doo Ho Choi, Won Park et al. · The Breast · 2010 · 64 citations · Full text

Medicine, Oncology, Surgery +16